Diagnostic enzymes are a crucial component of medical diagnostics, playing a vital role in the detection and monitoring of various diseases and health conditions. These specialized enzymes are used in diagnostic tests to measure specific biomarkers or to facilitate biochemical reactions that indicate the presence of certain diseases or abnormalities in the body.
The global diagnostic enzymes market is anticipated to increase by USD 1.2 billion till 2029 at an average annual growth of 4.1 percent as per the latest market estimates.
This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the type, product type, application, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.
The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.
The global market for diagnostic enzymes can be segmented by type: clinical enzymes, molecular enzymes. In 2022, the molecular enzymes segment made up the largest share of revenue generated by the diagnostic enzymes market.
Diagnostic enzymes market is further segmented by product type: acid phosphatase (AP), alanine aminotransferase (ALT), amylase, Bst polymerase (LAMP enzyme), lyophilized polymerase, creatine kinase (CK), glucose oxidase/glucose dehydrogenase, hot start Taq polymerase, lactate oxidase, M-MLV reverse transcriptase, T7 RNA polymerase, Taq polymerase, others.
Based on application, the diagnostic enzymes market is segmented into: autoimmune diseases, cardiology, diabetes, infectious diseases, nephrology, oncology, others. The oncology segment is estimated to account for the largest share of the global diagnostic enzymes market.
On the basis of region, the diagnostic enzymes market also can be divided into: Asia-Pacific, Europe, North America, Rest of the World (RoW). North America held the highest share in the global diagnostic enzymes market. However, Asia-Pacific is forecast to register the highest CAGR during the forecast period 2023 - 2029.
The report also provides analysis of the key companies of the industry and their detailed company profiles including Aldevron, L.L.C. (Danaher Corporation), Amano Enzyme Inc., Ampliqon A/S, Codexis, Inc., Creative BioMart, Inc. dba Creative Enzymes, EKF Diagnostics Holdings plc, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, Kaneka Eurogentec S.A., Merck KGaA, Promega Corporation, Sekisui Diagnostics, LLC, Solis BioDyne OU, Takara Bio Inc., Thermo Fisher Scientific Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Why Choose This Report
Gain a reliable outlook of the global diagnostic enzymes market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Market Segments Covered in Global Diagnostic Enzymes Industry Analysis:
i.) Type
- Clinical enzymes
- Molecular enzymes
ii.) Product type
- Acid phosphatase (AP)
- Alanine aminotransferase (ALT)
- Amylase
- Bst polymerase (LAMP enzyme)
- Lyophilized polymerase
- Creatine kinase (CK)
- Glucose oxidase/glucose dehydrogenase
- Hot start Taq polymerase
- Lactate oxidase
- M-MLV reverse transcriptase
- T7 RNA polymerase
- Taq polymerase
- Others
iii.) Application
- Autoimmune diseases
- Cardiology
- Diabetes
- Infectious diseases
- Nephrology
- Oncology
- Others
iv.) Region
- Asia-Pacific
- Europe
- North America
- Rest of the World (RoW)
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL DIAGNOSTIC ENZYMES MARKET BY TYPE
5.1 Clinical enzymes
5.2 Molecular enzymes
PART 6. GLOBAL DIAGNOSTIC ENZYMES MARKET BY PRODUCT TYPE
6.1 Acid phosphatase (AP)
6.2 Alanine aminotransferase (ALT)
6.3 Amylase
6.4 Bst polymerase (LAMP enzyme)
6.5 Lyophilized polymerase
6.6 Creatine kinase (CK)
6.7 Glucose oxidase/glucose dehydrogenase
6.8 Hot start Taq polymerase
6.9 Lactate oxidase
6.10 M-MLV reverse transcriptase
6.11 T7 RNA polymerase
6.12 Taq polymerase
6.13 Others
PART 7. GLOBAL DIAGNOSTIC ENZYMES MARKET BY APPLICATION
7.1 Autoimmune diseases
7.2 Cardiology
7.3 Diabetes
7.4 Infectious diseases
7.5 Nephrology
7.6 Oncology
7.7 Others
PART 8. GLOBAL DIAGNOSTIC ENZYMES MARKET BY REGION
8.1 Asia-Pacific
8.2 Europe
8.3 North America
8.4 Rest of the World (RoW)
PART 9. COMPANY PROFILES
9.1 Aldevron, L.L.C. (Danaher Corporation)
9.2 Amano Enzyme Inc.
9.3 Ampliqon A/S
9.4 Codexis, Inc.
9.5 Creative BioMart, Inc. dba Creative Enzymes
9.6 EKF Diagnostics Holdings plc
9.7 Enzo Life Sciences, Inc.
9.8 F. Hoffmann-La Roche AG
9.9 Kaneka Eurogentec S.A.
9.10 Merck KGaA
9.11 Promega Corporation
9.12 Sekisui Diagnostics, LLC
9.13 Solis BioDyne OU
9.14 Takara Bio Inc.
9.15 Thermo Fisher Scientific Inc.
DISCLAIMER
The Digital Transformation Diagnostic Service Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Mobile Diagnostic Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...
Market Overview
The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...
Market Overview
The North America Ambulance Equipment Market is expected to witness robust growth from 2024 to 2034, driven by the increasing incidence of medical emergencies, advancements in medical technologies, and the expanding healthcare infrastructure. By 2034, the market is proje...
Market Overview
The Global Ambulance Equipment Market is projected to experience significant growth over the next decade, driven by technological advancements, increasing incidence of chronic diseases, and a rising number of road accidents. The market, valued at USD XX.XX billion in 202...